Background T-cell receptor (TCR) and B-cell (BCR) repertoire profiling holds great potential for understanding disease mechanisms the development of new therapeutics in infectious diseases, autoimmunity immuno-oncology. However, this could be greatly improved by combining information about clonotypes with immuno-phenotypes T B cells. Methods To facilitate these studies, we developed a novel tec...